Furthermore, we examined the phenotype of DCs in the peripheral blood (PB) of 20 advanced NSCLC patients treated at our hospital, comprising 9 patients with EGFR mutation and 11 patients with WT. This evidence concerns the gene EGFR and non-small cell lung carcinoma.